➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Moodys
Boehringer Ingelheim
Merck
Baxter

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Mcneil Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MCNEIL, and what generic and branded alternatives to MCNEIL drugs are available?

MCNEIL has sixteen approved drugs.



Summary for Mcneil
US Patents:0
Tradenames:9
Ingredients:6
NDAs:16

Drugs and US Patents for Mcneil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil Cons BENADRYL diphenhydramine hydrochloride INJECTABLE;INJECTION 006146-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Mcneil Consumer MOTRIN ibuprofen TABLET;ORAL 017463-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Mcneil METHOCARBAMOL AND ASPIRIN aspirin; methocarbamol TABLET;ORAL 089193-001 Feb 12, 1986 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Mcneil Cons BENADRYL diphenhydramine hydrochloride ELIXIR;ORAL 005845-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Mcneil MOTRIN ibuprofen SUSPENSION/DROPS;ORAL 020476-001 May 25, 1995 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Mcneil Consumer MOTRIN ibuprofen TABLET;ORAL 017463-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Mcneil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 4,915,950 ⤷  Free Forever Trial
Mcneil Ped MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020135-002 Nov 16, 1994 5,320,855*PED ⤷  Free Forever Trial
Mcneil Ped MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020135-002 Nov 16, 1994 5,215,755*PED ⤷  Free Forever Trial
Mcneil Consumer MOTRIN ibuprofen SUSPENSION;ORAL 019842-001 Sep 19, 1989 5,374,659*PED ⤷  Free Forever Trial
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 6,098,632 ⤷  Free Forever Trial
Mcneil Ped MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020135-001 Nov 16, 1994 5,215,755*PED ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Boehringer Ingelheim
McKinsey
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.